Learn Best Practices for Managing Adverse Events Associated With Novel Therapies for Patients With Hematologic Malignancies
  • Program Overview
    Learn Best Practices for Managing Adverse Events Associated With Novel Therapies for Patients With Hematologic Malignancies
    Jae H. Park, MD, and Anas Younes, MD, provide expert perspectives on identifying and managing CRS and TLS for your patients being treated for various hematologic malignancies. These activities include commentaries with expert insights on CRS and TLS, along with shareable downloadable slidesets.
  • Featured content
    Anas Younes, MD, discusses standards of care for patients with or at risk of TLS, including risk stratification and optimal use of available agents for prophylaxis and treatment of TLS.
  • Featured content
    In this CME/CE-certified module, Jae H. Park, MD, discusses the association of novel anticancer agents with cytokine release syndrome and reviews optimal current assessment, prevention, and treatment.
  • Featured content
    In this downloadable slideset, Jae H. Park, MD, discusses the association of novel anticancer agents with cytokine release syndrome and reviews optimal current assessment, prevention, and treatment.
    Date Posted: 3/10/2017
  • 1
  • 2
  • 3
  • 4

Latest Content

4 of 4 Shown
4 of 4 Shown
Show 0 More
Loading...